NURO is about to start moving. The selling is almost over and the January effect has started in middle December recently. NURO should be trading much higher and at least at cash right now. At the current cash burn rate they could flop for 3-4 years but they wont. Their products are still good yet have fallen on hard times. The Digiscope flop it behind us, NC Stat will get reimbursement soon at a lower rate, and Advance will kick in to make up for it. When NURO starts coming out with treatments they will be back where they used to be before they lost the love. Someone will be taking notice soon.
Deerfield has increased it's overall stack to 13+ %; and has recently taken on an activist role (see NTMD); therefore, I feel, trading at a significant neg Enterprise Value; and hopefully a stop in bonehead moves (Digiscope), this company will trade higher